Indutrade strengthens its position in med-technology
Indutrade today acquired all of the shares in the Norwegian company Brinch AS
with annual sales of approximately SEK 15 million. Brinch markets products,
technical service and support to private and public sector ophthalmology
departments in Scandinavia. After the acquisition of EssMed AB in Sweden last
spring, Brinch is Indutrade's second acquisition in this product segment.
Organisationally, Brinch will be included in the Industrial Components business
area, which had net sales of SEK 940 million in 2007.
The acquisition is expected to have a marginally positive impact on Indutrade's
earnings per share.
Stockholm, 6 November 2008
INDUTRADE AB (publ)
.
For further information, please contact:
Johnny Alvarsson, President and CEO, tel. +46 70 589 17 95
About Indutrade
Indutrade markets and sells components, systems and services with a high-tech
content within selected niches. Indutrade's business is distinguished by:
• High-tech products for recurring needs
• Growth through a structured and tried-and-tested acquisition strategy
• A decentralised organisation characterised by an entrepreneurial spirit
The Group is structured into four business areas: Engineering & Equipment, Flow
Technology, Industrial Components and Special Products. Indutrade's sales
totalled SEK 5 673 million in 2007, generating operating income of SEK 650
million before depreciation of intangible assets. Indutrade is listed on the OMX
Nordic Exchange Stockholm.
